NYSE:BAX - Baxter International Stock Price, News, & Analysis

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International announced a quarterly dividend on Tuesday, November 13th. Shareholders of record on Monday, December 3rd will be paid a dividend of $0.19 per share on Wednesday, January 2nd. This represents a $0.76 annualized dividend and a yield of 1.17%. The ex-dividend date of this dividend is Friday, November 30th. View Baxter International's Dividend History.

Baxter International declared that its Board of Directors has authorized a share repurchase program on Tuesday, November 13th 2018, which allows the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy up to 6.1% of its shares through open market purchases. Shares repurchase programs are often a sign that the company's board believes its stock is undervalued.

Baxter International Inc (NYSE:BAX) posted its earnings results on Wednesday, October, 31st. The medical instruments supplier reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.74 by $0.06. The medical instruments supplier earned $2.77 billion during the quarter, compared to analysts' expectations of $2.79 billion. Baxter International had a return on equity of 17.67% and a net margin of 10.90%. Baxter International's revenue was up 2.2% compared to the same quarter last year. During the same period last year, the business posted $0.64 EPS. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, February 7th 2019. View Earnings Estimates for Baxter International.

Baxter International issued an update on its fourth quarter earnings guidance on Wednesday, October, 31st. The company provided EPS guidance of $0.71-0.73 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.77. Baxter International also updated its FY 2018 guidance to $2.98-3.00 EPS.

15 brokerages have issued 12 month target prices for Baxter International's shares. Their forecasts range from $66.00 to $85.00. On average, they anticipate Baxter International's share price to reach $74.00 in the next twelve months. This suggests a possible upside of 13.4% from the stock's current price. View Analyst Price Targets for Baxter International.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 2 sell ratings, 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

News articles about BAX stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Baxter International earned a news impact score of 0.9 on InfoTrie's scale. They also gave press coverage about the medical instruments supplier a news buzz of 9.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days.

Some companies that are related to Baxter International include 3M (MMM), Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ResMed (RMD), ABIOMED (ABMD), DexCom (DXCM), Teleflex (TFX), Hill-Rom (HRC), Haemonetics (HAE), Globus Medical (GMED), ICU Medical (ICUI), Insulet (PODD) and Penumbra (PEN).

Baxter International's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.41%), FMR LLC (5.52%), AQR Capital Management LLC (1.26%), Standard Life Aberdeen plc (1.08%), Veritas Asset Management LLP (0.89%) and Janus Henderson Group PLC (0.81%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including Veritas Asset Management LLP, BlackRock Inc., Wells Fargo & Company MN, Point72 Asset Management L.P., Mitsubishi UFJ Trust & Banking Corp, TIAA CREF Investment Management LLC, The Manufacturers Life Insurance Company and Acadian Asset Management LLC. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, Peter S Hellman and Scott Pleau. View Insider Buying and Selling for Baxter International.

BAX stock was acquired by a variety of institutional investors in the last quarter, including Standard Life Aberdeen plc, Schroder Investment Management Group, FMR LLC, Prudential Financial Inc., Thrivent Financial for Lutherans, Man Group plc, Janus Henderson Group PLC and Stevens Capital Management LP. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $65.23.

Baxter International has a market capitalization of $35.39 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $2.48 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.

The official website for Baxter International is http://www.baxter.com.

Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]